What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal.

European journal of breast health Pub Date : 2021-12-30 eCollection Date: 2022-01-01 DOI:10.4274/ejbh.galenos.2021.2021-11-1
Diana Simão, Mariana Sardinha, Ana Filipa Reis, Ana Sofia Spencer, Ricardo Luz, Sónia Oliveira
{"title":"What Has Changed During the COVID-19 Pandemic? - The Effect on an Academic Breast Department in Portugal.","authors":"Diana Simão,&nbsp;Mariana Sardinha,&nbsp;Ana Filipa Reis,&nbsp;Ana Sofia Spencer,&nbsp;Ricardo Luz,&nbsp;Sónia Oliveira","doi":"10.4274/ejbh.galenos.2021.2021-11-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>One year ago, Portugal entered its first lockdown because of the coronavirus disease-2019 (COVID-19) pandemic. The impact of this on delays in cancer diagnosis and treatment is a major concern, which may negatively affect the outcomes of these patients.</p><p><strong>Materials and methods: </strong>This retrospective, single-center analysis compared the clinical and pathological characteristics of breast cancer (BC) patients referred to a medical oncology first appointment between March 2020 and 2021, with the same period in the previous year.</p><p><strong>Results: </strong>Strikingly, there was a 40% reduction in the number of BC patients during lockdown. However, there was a statistically significant increase in the proportion of metastatic BC patients admitted for the first time for systemic therapy (13.6% vs. 28.9%, p = 0.003). Additionally, a statistically significant increase in the number of patients with bilateral early BC at diagnosis after March 2020 was found (7.2% vs. 1.9%, p = 0.043).</p><p><strong>Conclusion: </strong>These findings support international recommendations for an accelerated restoration of BC screening, to reduce incidence of advanced breast cancer at diagnosis and mitigate the expected impact of the COVID-19 pandemic on patients with cancer. Further work is needed to examine in detail the impact of measures to manage the COVID-19 pandemic on breast cancer outcomes.</p>","PeriodicalId":11885,"journal":{"name":"European journal of breast health","volume":" ","pages":"74-78"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734514/pdf/ejbh-18-74.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of breast health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/ejbh.galenos.2021.2021-11-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Introduction: One year ago, Portugal entered its first lockdown because of the coronavirus disease-2019 (COVID-19) pandemic. The impact of this on delays in cancer diagnosis and treatment is a major concern, which may negatively affect the outcomes of these patients.

Materials and methods: This retrospective, single-center analysis compared the clinical and pathological characteristics of breast cancer (BC) patients referred to a medical oncology first appointment between March 2020 and 2021, with the same period in the previous year.

Results: Strikingly, there was a 40% reduction in the number of BC patients during lockdown. However, there was a statistically significant increase in the proportion of metastatic BC patients admitted for the first time for systemic therapy (13.6% vs. 28.9%, p = 0.003). Additionally, a statistically significant increase in the number of patients with bilateral early BC at diagnosis after March 2020 was found (7.2% vs. 1.9%, p = 0.043).

Conclusion: These findings support international recommendations for an accelerated restoration of BC screening, to reduce incidence of advanced breast cancer at diagnosis and mitigate the expected impact of the COVID-19 pandemic on patients with cancer. Further work is needed to examine in detail the impact of measures to manage the COVID-19 pandemic on breast cancer outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19大流行期间发生了什么变化?-对葡萄牙学术乳房部门的影响。
导读:一年前,由于冠状病毒病-2019 (COVID-19)大流行,葡萄牙首次进入封锁状态。这对癌症诊断和治疗延误的影响是一个主要问题,这可能对这些患者的预后产生负面影响。材料和方法:这项回顾性的单中心分析比较了2020年3月至2021年3月期间首次就诊的乳腺癌(BC)患者的临床和病理特征,并与上一年同期进行了比较。结果:引人注目的是,在封锁期间,BC患者数量减少了40%。然而,首次接受全身治疗的转移性BC患者的比例有统计学意义的增加(13.6%比28.9%,p = 0.003)。此外,2020年3月后诊断时双侧早期BC的患者数量有统计学意义的增加(7.2% vs 1.9%, p = 0.043)。结论:这些发现支持加速恢复BC筛查的国际建议,以降低诊断时晚期乳腺癌的发病率,并减轻COVID-19大流行对癌症患者的预期影响。需要进一步开展工作,详细审查管理COVID-19大流行的措施对乳腺癌预后的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Rare Case of Concurrent Lupus Mastitis and Sarcoidosis in a 62-Year-Old Female High Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer The Effect of Informative Mobile App Use on Anxiety, Distress, and Quality of Life of Women With Breast Cancer Bioinformatic Investigation of Genetic Changes in Paraoxonase Genes in Breast Cancer and Breast Cancer Subtypes Skin Staining After Injection of Superparamagnetic Iron Oxide for Sentinel Lymph Node Dissection: A Retrospective Study of Two Protocols for Injection and Long-Term Follow-Up
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1